Dual-eligible billing has its own sequencing and balance-billing prohibitions, and the most common error is charging the patient anything at all. For QMB beneficiaries, billing the patient for Medicare cost-sharing is prohibited regardless of what Medicaid pays.
Patients eligible for both Medicare and Medicaid are among the most straightforward to bill and the easiest to get wrong, because the rule that governs them is one most billing staff have never been told.
The sequencing
Medicare pays first. Medicaid considers the remaining balance, subject to the state's rules and its own fee schedule. That part is intuitive.
The part that is not
For patients in the relevant categories, the provider generally may not bill the patient for Medicare cost-sharing — deductibles, coinsurance, copays. Even where Medicaid pays little or nothing toward that balance, because its rate is lower than what Medicare already paid, the patient is still protected.
This is the trap. The remittance shows a remaining balance, the system routes it to patient responsibility, and a statement goes out. The balance was never the patient's, and billing it is a prohibited practice rather than a billing error.
The controls
- Flag dual-eligible patients at registration, so the account never routes to patient responsibility by default.
- Bill Medicaid even when you expect no payment. The adjudication is what establishes the balance is not billable.
- Write off the remainder as a contractual obligation, and record it that way rather than as bad debt.
- Review your statements for dual-eligible accounts periodically. This error is systematic when it happens, not occasional.
The financial exposure is small per claim. The compliance exposure is not, and it compounds quietly because the patients least likely to dispute a bill are the ones this affects.
Check QMB status at eligibility, not at billing
QMB status is returned in the Medicare eligibility response. Catching it at check-in prevents the balance from ever being created, which is the only reliable control — once a statement has gone out, the problem exists whether or not you reverse it.
Build it into the same check that confirms coverage rather than treating it as a separate lookup.
Suppress the statement, not just the balance
Many practice systems will generate a patient statement for any non-zero balance regardless of payer rules. Adjusting the balance after the statement has printed is a correction; suppressing statements for QMB accounts is a control.
Ask your system how it flags these, and test it with a real account.
Automatic crossover is not universal
Most dual claims cross from Medicare to Medicaid automatically, and some do not — depending on the state, the plan and the enrollment record. A crossover that silently fails looks like an unpaid claim aging quietly.
Watch the Medicaid side of dual claims rather than assuming the crossover happened.
Common questions
- Can I bill a dual-eligible patient for a copay?
- For QMB beneficiaries, no. Federal rules prohibit billing them for Medicare deductibles, coinsurance and copays, even where Medicaid pays nothing toward it.
- What is a QMB?
- A Qualified Medicare Beneficiary — a dual-eligible category with specific balance-billing protections. QMB status appears on the Medicare eligibility response.
- How do dual-eligible claims get sequenced?
- Medicare pays first, then the claim crosses over to Medicaid for any remaining cost-sharing Medicaid covers. The patient sits outside that sequence entirely.
- What if Medicaid pays nothing on the crossover?
- You accept it. Medicaid frequently pays zero because its allowable is below what Medicare already paid, and that outcome still does not create a patient balance.
- How do I identify dual-eligible patients?
- Check the Medicare eligibility response, which returns QMB status, and verify Medicaid separately. Relying on the patient to explain their coverage is where the errors start.
Denials Piling Up?
We handle the revenue cycle end to end — coding by certified coders, claim submission, denial management and appeals, and A/R follow-up, with six reported numbers every month.